Weighted Average Number of Shares Outstanding, Basic of LUMOS PHARMA, INC. from 30 Sep 2010 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
LUMOS PHARMA, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2010 to 30 Sep 2024.
  • LUMOS PHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2024 was 8,327,488, a 4.4% increase year-over-year.
  • LUMOS PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 8,145,155, a 2.7% decline from 2022.
  • LUMOS PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 8,373,821, a 0.47% increase from 2021.
  • LUMOS PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8,334,516, a 23% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

LUMOS PHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 8,327,488 +349,031 +4.4% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 8,112,566 -52,037 -0.64% 01 Apr 2024 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 8,104,905 -135,036 -1.6% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 8,145,155 -228,666 -2.7% 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2024 2023 FY
Q3 2023 7,978,457 -409,572 -4.9% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 8,164,603 -201,842 -2.4% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 8,239,941 -118,028 -1.4% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 8,373,821 +39,305 +0.47% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 8,388,029 +30,638 +0.37% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 8,366,445 -365,704 -4.2% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 8,357,969 +41,081 +0.49% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 8,334,516 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 8,357,391 +64,079 +0.77% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 8,732,149 +439,340 +5.3% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 8,316,888 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q3 2020 8,293,312 +6,949,829 +517% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 8,292,809 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q3 2019 1,343,483 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q1 2017 29,213,488 +356,544 +1.2% 01 Jan 2017 31 Mar 2017 10-Q 05 May 2017 2017 Q1
Q4 2016 28,979,327 +392,742 +1.4% 01 Oct 2016 31 Dec 2016 10-K 06 Mar 2017 2016 FY
Q3 2016 28,983,561 +248,793 +0.87% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 28,891,827 +230,239 +0.8% 01 Apr 2016 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 28,856,944 +638,313 +2.3% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q4 2015 28,586,585 01 Oct 2015 31 Dec 2015 10-K 06 Mar 2017 2016 FY
Q3 2015 28,734,768 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016 2016 Q3
Q2 2015 28,661,588 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 28,218,631 +612,721 +2.2% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016 2016 Q1
Q1 2014 27,605,910 01 Jan 2014 31 Mar 2014 10-Q/A 24 Aug 2015 2015 Q1
Q4 2012 20,779,450 +14,714,908 +243% 01 Oct 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
Q3 2012 20,887,689 +17,229,567 +471% 01 Jul 2012 30 Sep 2012 10-Q 31 Oct 2012 2012 Q3
Q2 2012 20,684,944 +17,037,971 +467% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 20,613,146 +16,977,102 +467% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 6,064,542 01 Oct 2011 31 Dec 2011 10-K 30 Mar 2012 2011 FY
Q3 2011 3,658,122 +286,198 +8.5% 01 Jul 2011 30 Sep 2011 10-Q 31 Oct 2012 2012 Q3
Q2 2011 3,646,973 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2
Q1 2011 3,636,044 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
Q3 2010 3,371,924 01 Jul 2010 30 Sep 2010 10-Q/A 17 Jan 2012 2011 Q3

LUMOS PHARMA, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 8,145,155 -228,666 -2.7% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2024 2023 FY
2022 8,373,821 +39,305 +0.47% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 8,334,516 +1,556,584 +23% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
2020 6,777,932 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022 2021 FY
2016 28,979,327 +392,742 +1.4% 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2017 2016 FY
2015 28,586,585 +747,712 +2.7% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2017 2016 FY
2014 27,838,873 +2,563,694 +10% 01 Jan 2014 31 Dec 2014 10-K 06 Mar 2017 2016 FY
2013 25,275,179 +4,495,729 +22% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 20,779,450 +14,714,908 +243% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 6,064,542 +2,712,211 +81% 01 Jan 2011 31 Dec 2011 10-K 30 Mar 2012 2011 FY
2010 3,352,331 01 Jan 2010 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.